Evidence map›Paper›PMID 40983380›Full record

GuidelineCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2025

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy.

Kerri L Schellenberg, Gudrun Caspar-Bell, Colin Ellis, Wendy Johnston, Alexandra King, Malcolm King, Lawrence Korngut, Brendan Kushneriuk, Andrea J Lavoie, Reid McGonigle and 7 more

Abstract readPractice Guideline
In one paragraph

Guideline in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kerri L SchellenbergDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont. kerri.schellenberg@usask.ca.
Gudrun Caspar-BellDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Colin EllisDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Wendy JohnstonDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Alexandra KingDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Malcolm KingDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Lawrence KorngutDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Brendan KushneriukDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Andrea J LavoieDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Reid McGonigleDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Julia NewtonDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Colleen O'ConnellDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Christen ShoesmithDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Oksana SuchowerskyDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Jodi Warman-ChardonDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Shane WunderDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.
Gerald PfefferDivision of Neurology (Schellenberg, Newton), Division of Endocrinology (Caspar-Bell), Division of Respirology, Critical Care, and Sleep Medicine (Ellis), Department of Medicine; Pewaseskwan Indigenous Health and Wellness (A. King, M. King); Department of Medicine (A. King), Community Health and Epidemiology (M. King), Physical Medicine and Rehabilitation (Kushneriuk, Wunder); Division of Cardiology, Department of Medicine (Lavoie); Department of Family Medicine (McGonigle), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology, Department of Medicine (Johnston), University of Alberta, Edmonton, Alta.; Department of Clinical Neurosciences (Korngut, Pfeffer), University of Calgary, Calgary, Alta.; Dalhousie Medicine New Brunswick (O'Connell), Fredericton, NB; Division of Neurology, London Health Sciences Centre (Shoesmith), Western University, London, Ont.; Departments of Medicine (Neurology) and Medical Genetics (Suchowersky), University of Alberta, Edmonton, Alta.; Department of Medicine (Neurology), Ottawa Neuromuscular Centre (Warman-Chardon), University of Ottawa, Ottawa, Ont.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough rare in the general population, spinal bulbar muscular atrophy (SBMA) is an X-linked recessive neuromuscular condition that is highly prevalent in people identifying as First Nations and Métis in western Canada. The aim of this guideline is to improve and standardize care of SBMA, and to increase awareness of the condition.

methodsOur interdisciplinary working group conducted a needs assessment survey to aid in the development of guideline topic questions, followed by a literature search, evidence review, and external review by health practitioners and people with lived experience. We followed the ADAPTE framework to evaluate the only pre-existing SBMA guideline (2020 French national protocol) and the 2020 Canadian amyotrophic lateral sclerosis guideline for appropriateness of adaptation. Our process adhered to the Appraisal of Guidelines for Research and Evaluation (AGREE II) tool; used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach; and followed the Guidelines International Network-McMaster Guideline Development Checklist. Indigenous community engagement was led by the Pewaseskwan Indigenous Research Group, who participated in the development of the guideline. RECOMMENDATIONS: We developed 41 recommendations to address the continuum of care in SBMA, including diagnosis; multidisciplinary teams; management of limb and bulbar symptoms, respiratory and cardiac complications, and multisystem symptoms; female carriers; emotional supports; and considerations for Indigenous people. Spinal bulbar muscular atrophy is best managed by multidisciplinary teams that can address both its motor and nonmotor manifestations, including cardiac involvement, sensory symptoms, and metabolic dysfunction. Concerns for female carriers may include symptom management and genetic counselling. Providers should ensure culturally appropriate care for Indigenous people.

interpretationIn this guideline, we provide health care professionals with a culturally responsive standard of care for SBMA, and hope this will translate into improved quality of life for people affected by SBMA.

Indexed as

Bulbo-Spinal Atrophy, X-LinkedCanadaHumansMale

Identifiers

PMID40983380
PMCPMC12479135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.